Start Date
Immediate
Expiry Date
26 Jul, 25
Salary
223000.0
Posted On
26 Apr, 25
Experience
0 year(s) or above
Remote Job
Yes
Telecommute
Yes
Sponsor Visa
No
Skills
Design Control, Medical Devices, Drug Free Workplace, Drug Development, Addition, Commercialization, Base Pay, Color, Jira, Disabilities, Financial Data
Industry
Information Technology/IT
Our mission is to detect cancer early, when it can be cured. We are working to change the trajectory of cancer mortality and bring stakeholders together to adopt innovative, safe, and effective technologies that can transform cancer care.
We are a healthcare company, pioneering new technologies to advance early cancer detection. We have built a multi-disciplinary organization of scientists, engineers, and physicians and we are using the power of next-generation sequencing (NGS), population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges.
GRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies.
For more information, please visit grail.com.
In this role, you will manage programs & projects for the Pharma Partnerships (PhP) business. Your responsibilities include overseeing (1) portfolio, strategic and operational initiatives as well as (2) development and commercialization collaborations with external pharma partners. You will also be responsible for setting up program core teams and sub-teams meetings, directing project planning, maintaining communication and alignment between internal and external teams, and overseeing development execution of future clinical offerings.
PREFERRED QUALIFICATIONS
How To Apply:
Incase you would like to apply to this job directly from the source, please click here
Program management of Pharma Partnerships (PhP) business as related to development & commercialization collaborations with external Pharma Partners: